(R)-2-((tert-Butoxycarbonyl)amino)-2-methylbutanoic acid, 95.0%, 5g

(1R,2S)-1-PHENYL-2-PYRROLIDIN-1-YL-PROPAN-1-OL, 97.0%, 25g

HPLC column NUCLEODUR® NH2 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

6-Bromofuro[3,2-b]pyridine-2-carbaldehyde, 98%, 250mg

(3-(Hydroxymethyl)-4-(trifluoromethoxy)phenyl)boronic acid, 97%, 5g

2-Amino-5-chloro-6-methylpyrazine, 95.0%, 500mg

N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea, 98%, 100mg

4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidine, 96.0%, 250mg

Tert-butyl(7r)-7-hydroxy-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 97%, 100mg

2-Hydroxy-3,3-dimethylbutanoic acid, 97%, 10g

2-(tert-Butoxycarbonyl)-2-azabicyclo[2.1.1]hexane-1-carboxylic acid, 95.0%, 5g

7-(Trifluoromethyl)-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 250mg

2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-, 98%, 10mg